Qinghai Spring Medicinal Resources Technology Co., Ltd. announced earnings guidance for the full year 2018. The Company predicts a decrease of between RMB 226,142,300 and RMB 242,142,300 in the net profit belonging to shareholders of the listed company in 2018 compared with the same period of the year before, with a year-on-year decrease between 72.55% and 77.69% (the disclosed statistics according to relevant regulations); and with a decrease of between RMB 225 million and RMB 241 million in the net profit belonging to shareholders of the listed company, with a year-on-year decrease between 72.45% and 77.61% (restated and adjusted data). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss in 2018 will decrease by between RMB 228,110,300 and RMB 244,110,300 compared with the same period of the year before, with a year-on-year decrease between 84.01% and 89.91% (the disclosed statistics according to relevant regulations); and with a decrease of between RMB 226,968,000 and RMB 242,968,000 in the net profit belonging to shareholders of the listed company, with a year-on-year decrease between 83.95% and 89.87% (restated and adjusted data).